Naranie Shanmuganathan

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Mass Spectrometry

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

British journal of haematology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

David T Yeung, Naranie Shanmuganathan, John Reynolds, Susan Branford, Mannu Walia, Agnes Sm Yong, Jake Shortt, Lynette Chee, Nicholas Viiala, Ilona Cunningham, David Morrall Ross, Alwyn Bernard D'Souza, Matthew Wright, Rosemary Anne Harrup, Cecily Jane Forsyth, Robin Filshie, Steven W Lane, Peter J Browett, Carolyn S Grove, Andrew A Grigg, Timothy P Hughes
Asciminib Monotherapy as Frontline Treatment of Chronic-Phase Chronic Myeloid Leukemia: Results from the ASCEND Study. Blood (2024)
Naranie Shanmuganathan, Andrew Grigg
A critical review of management of allogeneic transplant-eligible adults with Ph+ acute lymphoblastic leukaemia. British journal of haematology (2024)
Yazad Darius Irani, Chung Hoow Kok, Jade Clarson, Naranie Shanmuganathan, Susan Branford, David T Yeung, David Morrall Ross, Timothy P Hughes, Agnes Sm Yong
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia. Blood advances (2023)
Ilaria Stefania Pagani, Naranie Shanmuganathan, Phuong Dang, Verity A Saunders, Randall Grose, Chung Hoow Kok, Jane James, Molly Tolland, Jodi A Braley, Haley Kristen Altamura, David T O Yeung, Susan Branford, Agnes Sm Yong, Timothy P Hughes, David Morrall Ross
Lineage-specific detection of residual disease predicts relapse in chronic myeloid leukemia patients stopping therapy. Blood (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung H Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 141 (9) (2023)
Chung Hoow Kok, Verity A Saunders, Phuong Dang, Naranie Shanmuganathan, Deborah L White, Susan Branford, David Yeung, Timothy P Hughes
Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib. Blood cancer journal 13 (1) (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung H Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 141 (9) (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung H Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 141 (9) (2023)
Michael J Mauro, Timothy P Hughes, Dong-Wook Kim, Delphine Rea, Jorge E Cortes, Andreas Hochhaus, Koiji Sasaki, Massimo Breccia, Moshe Talpaz, Oliver Ottmann, Hironobu Minami, Yeow Tee Goh, Daniel J DeAngelo, Michael C Heinrich, Valle Gómez-García de Soria, Philipp le Coutre, Francois-Xavier Mahon, Jeroen J W M Janssen, Michael Deininger, Naranie Shanmuganathan, Mark Blaine Geyer, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Matthias Hoch, Fabian Lang
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results. Leukemia (2023)
David T O Yeung, Naranie Shanmuganathan, Timothy P Hughes
Asciminib: a new therapeutic option in chronic-phase CML with treatment failure. Blood 139 (24) (2022)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty M Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika M Kutyna, Hassan B Alkhateeb, Talha Badar, Paul Po-Shen Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter G Bardy, Ashanka Beligaswatte, David T Yeung, Mark R Litzow, Abhishek A Mangaonkar, Pratyush Giri, Cindy H Lee, Angelina Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William J Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung Hoow Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood (2022)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty M Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika M Kutyna, Hassan B Alkhateeb, Talha Badar, Paul Po-Shen Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter G Bardy, Ashanka Beligaswatte, David T Yeung, Mark R Litzow, Abhishek A Mangaonkar, Pratyush Giri, Cindy H Lee, Angelina Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William J Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung Hoow Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood (2022)
Liu Lu, Chung Hoow Kok, Phuong Dang, Susan Branford, Verity A Saunders, Naranie Shanmuganathan, David M Ross, Timothy P Hughes, David T O Yeung
Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment-free remission. British journal of haematology 198 (3) (2022)
Shady Adnan-Awad, Oscar Brück, Naranie Shanmuganathan, Timo Jarvinen, Hanna Lähteenmäki, Jay Klievink, Hazem Ibrahim, Soili Kytölä, Perttu Koskenvesa, Timothy P Hughes, Susan Branford, Matti Kankainen, Mohamed El Missiry
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation. Blood cancer journal 12 (4) (2022)
Naranie Shanmuganathan, Timothy P Hughes
Asciminib for chronic myeloid leukaemia: Next questions. British journal of haematology 199 (3) (2022)
Yotaro Ochi, Kenichi Yoshida, Ying-Jung Huang, Ming-Chung Kuo, Yasuhito Nannya, Ko Sasaki, Kinuko Mitani, Noriko Hosoya, Nobuhiro Hiramoto, Takayuki Ishikawa, Susan Branford, Naranie Shanmuganathan, Kazuma Ohyashiki, Naoto Takahashi, Tomoiku Takaku, Shun Tsuchiya, Nobuhiro Kanemura, Nobuhiko Nakamura, Yasunori Ueda, Satoshi Yoshihara, Rabindranath Bera, Yusuke Shiozawa, Lanying Zhao, June Takeda, Yosaku Watatani, Rurika Okuda, Hideki Makishima, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Masashi Sanada, Akifumi Takaori-Kondo, Satoru Miyano, Seishi Ogawa, Lee-Yung Shih
Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia. Nature communications 12 (1) (2021)
Naranie Shanmuganathan, Susan Branford
Multiplex technologies for the assessment of minimal residual disease and low-level mutation detection in leukaemia: mass spectrometry versus next-generation sequencing. British journal of haematology (2021)
Naranie Shanmuganathan, Susan Branford, Timothy P Hughes, Devendra Hiwase
Bone marrow fibrosis associated with long-term imatinib therapy: resolution after switching to a second-generation TKI. Blood advances 3 (3) (2020)
Naranie Shanmuganathan, Jodi A Braley, Agnes S M Yong, Devendra K Hiwase, David T Yeung, David Morrall Ross, Timothy P Hughes, Susan Branford
Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission. Blood 134 (1) (2019)
Naranie Shanmuganathan, Devendra Keshaorao Hiwase, David Morrall Ross
Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome. Leukemia & lymphoma 58 (12) (2017)